EARNINGS PER SHARE (Details) (USD $)	12 Months Ended
	Dec. 31, 2012		Dec. 31, 2011		Jun. 30, 2012	Jul. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	9,189,119		1,490,986
Number of warrants to purchase common stock (in shares)	7
Number of warrants that vest upon payment of notes	5
Aggregate shares of common stock issued upon exercise of warrants (in shares)					3,142,857
Common stock vested upon initial warrant (in shares)	2,041,165		612,594		392,857			635,873
Exercise price of warrants (in dollars per share)	$ 0.35		$ 1.08		$ 0.35
Average number of trading days prior to the payment of note taken to calculate the conversion price	5 days
Conversion price (in dollars per share)	$ 0.70					$ 1.08	$ 1.20
Number of months from date of issuance of Series A preferred stock taken for conversion of accrued dividends	6 months
Private Placement [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Aggregate shares of common stock issued upon exercise of warrants (in shares)	785,714
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	2,041,165	[1]	612,594	[1]
Stock options to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	158,409		287,745
Unvested restricted common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	300		1,096
Common stock issuable upon the assumed conversion of our convertible promissory notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	5,617,974	[2]	0	[2]
Common stock issuable upon the assumed conversion of our convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	368,637	[3]	232,408	[3]
Common stock issuable upon the assumed conversion of our Series A preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculating basic and diluted net loss per common share (in shares)	1,002,634	[4]	357,143	[4]

[1] As part of the June 2012 Note, Inter-Mountain received a total of seven warrants to purchase, if they all vest, an aggregate of 3,142,857 shares of common stock, which number of shares could increase based upon the terms and conditions of the warrants. The warrants have an exercise price of $0.35 per share, subject to certain pricing adjustments, and are exercisable, subject to vesting provisions and ownership limitations, until June 27, 2017. Warrants for 785,714 shares of common stock and 392,857 shares of common stock vested on June 27, 2012 and December 31, 2012, respectively, and only such shares of common stock have been included in this Table, based upon an exercise price of $0.35 per share of common stock. Each of the other five warrants vest upon the payment by Inter-Mountain of a related Investor Note.

[2] The outstanding principal balance and the accrued and unpaid interest of the June 2012 Note may be converted, at the option of Inter-Mountain, into shares of common stock at a conversion price of $0.35 per share, subject to certain pricing adjustments and ownership limitations. For the purposes of this Table, we have assumed a conversion price of $0.35 per share and no ownership limitations.

[3] The outstanding principal balance of the June 2011 Note and the July 2011 Note may be converted, at the option of Mr. Gray, into shares of common stock at a fixed conversion price of $1.20 per share and $1.08 per shares, respectively. The accrued and unpaid interest for each convertible note payable may be converted, at the option of Mr. Gray, into shares of common stock at a conversion price based upon the average of the five trading days prior to the payment date, which for the purposes of this Table we have assumed to be December 31, 2012.

[4] The outstanding Series A preferred stock and the accrued and unpaid dividends thereon are convertible into shares of the Company's common stock at the Company's option at any time after six-months from the date of issuance of the Series A preferred stock. The conversion price for the holder is fixed at $0.70 per share with no adjustment mechanisms, resets, ratchets, or anti- covenants other than the customary adjustments for stock splits. For the purposes of this Table, we have assumed a conversion price of $0.70 per share.